February 5, 2024- The American Cancer Society and Pfizer Inc. announced the launch of “Change the Odds: Uniting to Improve Cancer Outcomes™,” a three-year initiative to bridge the gap in cancer care disparities. Through $15 million in funding from Pfizer, the initiative aims to improve health outcomes in medically underrepresented communities across the United States by … [Read more...]
CME checklist for Joint Commission Inspections of medical equipment
January 31, 2024- The Joint Commission (TJC) is a medical standards regulatory agency in the U.S., and maintaining accreditation by TJC highly sought after by healthcare organizations. To maintain accreditation, healthcare facilities are inspected at least once every three years to ensure that TJC standards are continuously being met. Healthcare organizations should ensure … [Read more...]
The Ohio State University Wexner Medical Center and CVS Accountable Care collaborate
January 26, 2024- The Ohio State University Wexner Medical Center and CVS Accountable Care, part of CVS Health, announced the creation of an accountable care organization (ACO) to improve the quality of care for Medicare beneficiaries by Ohio State providers in central Ohio. This coordinated approach to delivering care is centered around each patient’s unique needs and … [Read more...]
Medela receives recognition for most trusted breast pump brand
January 18, 2024- Medela has been recognized as the Most Trusted Breast Pump Brand for the sixth year in a row as voted by North American shoppers through the 2024 BrandSpark® Consumer Survey. Each year, this survey polls thousands of North American consumers on the brands they trust the most. Medela has been honored to receive this prestigious recognition in 2019, 2020, … [Read more...]
Respiratory season: Coinfection risk
January 11, 2024- This year's respiratory season has looked much different than last year's. COVID-19, the flu, and RSV number continue to rise across the United States. Last winter, flu and RSV infections were already declining by the time hospitalizations from the omicron virus started to spike in December 2022. With all the respiratory illnesses circulating, how worried … [Read more...]
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
December 20, 2023- Medtronic plc announced it will participate in the 42nd annual J.P. Morgan healthcare conference on Monday, January 8, 2024. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 9:00 a.m. PST (11:00 a.m. CST). Immediately following the presentation, … [Read more...]
Select Health expands network, adding AdventHealth as new provider in Colorado
November 30, 2023- To help meet the growing need for healthcare services for Medicare beneficiaries, individuals, and families in Colorado, Select Health has announced the addition of AdventHealth to its Select Health provider network. This collaboration provides enhanced access to quality healthcare for consumers throughout Colorado. Access to this new provider network is … [Read more...]
A Supply Chain Renaissance
November 29, 2023- Through an ambitious modernization plan, Cardinal Health has big changes in store to improve facilities and the work experience of its employees. When a chief supply chain officer for a hospital or health system awards business to Cardinal Health, the gravity of that decision isn’t lost on James Sembrot, the company’s SVP, Supply Chain for U.S. Medical … [Read more...]
Tenet Healthcare to sell three South Carolina hospitals to Novant Health
November 21, 2023- Tenet Healthcare Corporation has entered into a definitive agreement with Novant Health for the sale of three Tenet hospitals and related operations in South Carolina for approximately $2.4 billion in cash (after-tax proceeds of approximately $1.750 billion). The transaction will include Coastal Carolina Hospital in Jasper County, Hilton Head Hospital in … [Read more...]
FRUZAQLA (fruquintinib), FDA Approved treatment for metastatic colorectal cancer, available at Biologics by McKesson
November 16, 2023- Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Takeda as a specialty pharmacy provider for FRUZAQLATM (fruquintinib). FRUZAQLA, approved by the U.S. Food and Drug Administration (FDA) on Nov. 8, 2023, is an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have … [Read more...]